Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Biomarkers Conference 2020

About Conference


Conference Series LLC Ltd welcomes you all to its new event 13th International Conference on  Biomarkers and clinical research conference is going to held in the city of Rome, Italy on November 25-26, 2020
 
Biomarkers Conference 2020 is 2-day scientific event, business meeting, trade fair and exhibition in the alluring city of Rome, Italy. Advancements in Biomarkers Conference 2020 brings an opportunity to discuss and learn about the advancements  in biomarker studies that access together a unique and international experts, scientists and decision makers both from academia and industry across the world to exchange their knowledge, research innovations & expertise in the arena of cancer treatment. It includes Keynote presentations, Poster presentations, Oral presentations (Speaker forum and Young research forum), and Exhibitions. This pinnacle brings together the senior level experts with a perfect union for multidisciplinary concert between scientists, innovators, academicians from all over the world working in the different fields of Cancer & Oncology Research.
 
 Call for Abstracts are open for Keynote Forum, Oral performances, E-Poster presentations, Speaker forums, Young research forums and scientific posters across the list of tracks publicized  in our website and we also welcome if they meet the objectives of the conference related to other topics that we are not mentioned. We hope and anticipate Advanced in Biomarkers to inspire a number of research centres, institutions and organizations and look forward to explore, innovations, new researches, findings and alliances, in this International Academic Forum Biomarkers Conference 2020.

Young Scientist Benefits:

  • Our conferences provide best Platform for your research through oral presentations.
  • Share the ideas with both eminent researchers and mentors.
  • Young Scientist Award reorganization certificate and memento to the winners
  • Young Scientists will get appropriate and timely information by this Forum.
  • Platform for collaboration among young researchers for better development
  • Award should motivate participants to strive to realize their full potential which could in turn be beneficial to the field as whole.

Deadline for Registrations:          

  • Till December 30, 2019 – $399   
  • Till January 30, 2020 – $449        
  • Till February 28, 2020 – $499

Market Analysis

Overview on biomarkers market:

The global biomarkers market has increased demand in recent years due to the rapid growth of population, rapid growth in IT industry which leads to increasing efforts towards the drug discovery. The entry of new entrepuners is expected to further boost the growth of the market. The advancements and innovations of biomarkers in medical arena such as research and cancer treatment will propel the future growth of the global biomarkers market. Biomarkers are broadly used to detect diseases such as immunological disorders, neurological disorders, cancer, cardiovascular disorders, and others. In the arena of oncology, recently three biological markers have been added to conventional breast cancer risk models to identify women at a higher risk of breast cancer

Global Vocal Biomarkers Market:

Sound vibrations are used as part of therapeutic healing for various mental health conditions such as anxiety and depression. Recent research studies, however, have greatly widen its applications into diagnosis of various diseases. On successful completion of clinical trials, HIPAA compliant vocal biomarker system would serve as much more alternative methods to current diagnostic techniques such as MRI, X-Ray, and CT scan. Research is also ongoing for identifying vocal biomarkers in diagnosis of Parkinson’s disease, traumatic brain injury, cognitive impairment, and respiratory disorders, which would open up a highly profitable avenue for growth for players in this industry. Since last 22 years companies dealing with vocal biomarkers is on researching by sampling data to provide accurate results and it has collected over 2.5 million voice samples in over 40 different languages.

Global Biomarkers Market is expected to USD 78.9 billion by 2024, from USD 31.4 billion in 2016 growing at a CAGR of 12.2% during the forecast period of 2017 to 2024. The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Western Europe (Germany, Italy, U.K, Spain, France, Rest of Western Europe)
  • Eastern Europe (Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa)

Summary (Overall Market of Biomarkers & Clinical Research with Statistics):

The global biomarkers market is expected to reach $45.55 Billion by 2020 from $24.10 Billion in 2015, at a CAGR of 13.58% between 2015 and 2020. Increasing healthcare expenditure & R&D spending and the increasing utility of biomarkers for diagnostics are expected to drive the market. Market growth will also be aided by the low cost of clinical trials in developing countries and new initiatives undertaken for biomarker research. On the other hand, the need for high capital investment, low benefit-cost ratio, poorly suited regulatory & reimbursement systems, and the high cost of tests and sample collection & storage are the major factors restraining the growth of this market.

The applications included in this report are diagnostics development, drug discovery & development, personalized medicine, disease risk assessment and other applications. The disease indication segments included in this report are cancer, cardiovascular disorders, neurological disorders, immunological disorders, and other diseases.

Major players in this market include QIAGEN N.V. (Netherlands), PerkinElmer, Inc. (U.S.), Merck & Co, Inc. (U.S.), Bio-Rad Laboratories (U.S.), Enzo Biochem (U.S.), EKF Diagnostics Holdings plc (U.S.), Meso Scale Diagnostics, LLC (U.S.), Singulex, Inc. (U.S.), BioSims Technologies (France), Cisbio Bioassays (France), and Signosis, Inc. (U.S.).

Past Conference Report

World Biomarkers 2018

9th World Biomarkers Congress was recently held during December 07-08, 2018 at Madrid, Spain.

Biomarkers Conference 2018 have taken up the scientific thoughts towards proving the importance of accurate diagnostics to be prevital towards the curing efficacy. The scientific meeting has laid path for the designing and development of research methodologies with the theme impact of “A New Era of Diagnosis and Clinical Research”. The discovery significance of the curative approach could be validated with the effectiveness of the associated clinical trials. Considering the technical integracy the Biomarkers conference embodied the research area of clinical trials and invited biopharma healthcare players. This integrated participation helped and will facilitate the technology transfer towards the recognition of biomolecular set in the form of either the specific molecule or the effective molecular pathway. The conference has tried grounding every aspect related to the Biomarkers Discovery covering the possible research areas.

This conference brought together Leading Clinical Researchers, Oncologists, Cancer Researchers, Professors, Pharmaceutical Companies, Diagnostics Companies, Students and other professionals in which many issues in Oncology & Cancer field were discussed in depth to provide up-to-date information to the world. On the other hand, the meeting provided an opportunity for networking.

The program highlights of the meeting were the eponymous lecture

·         Jianhua Luo, University of Pittsburgh, USA

·         Topolcan Ondrej, Charles University, Czech Republic

·         Wancai Yang, University of Illinois at Chicago, USA

·         Ashleigh McConnell, AMLo Biosciences Limited

Poster Evaluation Committee and the Winner:

Biomarkers Conference 2018 would like to acknowledge Dr.Topolcan Ondrej for his evaluation of the poster session and we are glad to congratulate Ms. Rocío Thompson-Bonilla, for receiving the Best Poster Award of the conference.

Conference Series LLC LTD takes its pleasure to thank all the Organizing Committee Members, Chairs and Co-chairs, Speakers, Students, Media Partners and all who supported the conference in every aspect for the magnificent presence at the venue.

Conference Series LLC LTD is overwhelmed to announce the commencement of its International Conference on Biomarkers and Clinical Research on November 25-26, 2020 at Rome, Italy.

For More details visit: Biomarkers Conference 2020

 We hope to see u soon with us at Biomarkers Conference 2020


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date November 25-26, 2020

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Past Conference Report

Supported By

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by